Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, July 25, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0575303/Peripheral-Vascular-Devices---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices
Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global peripheral vascular devices market. The report provides market landscape, competitive landscape and market trends information on the peripheral vascular devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Peripheral Vascular Stents, PTA Balloons, Inferior Vena Cava Filters, Aortic Stent Grafts, Synthetic Surgical Grafts, Peripheral Guidewires, Embolic Protection Devices and Peripheral Drug Eluting Balloons (DEB).
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within peripheral vascular devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Cordis Corporation, Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc. and C.R. Bard, Inc.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the peripheral vascular devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the peripheral vascular devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global peripheral vascular devices market and the factors shaping it.
1 Table of contents
1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 GlobalData Report Guidance 9
3 Disease Overview 10
3.1 Peripheral Vascular Disease 10
3.1.1 Etiology and Risk Factors 10
3.1.2 Pathophysiology 10
3.1.3 Peripheral Vascular Disease, Treatment Flow Model 11
3.1.4 Peripheral Vascular Disease - Diagnosis Rate 12
3.1.5 Peripheral Vascular Devices - Prescription Rate 12
3.1.6 Device Based Treatment Modalities for Peripheral Vascular Disease 12
3.2 Abdominal Aortic Aneurysm (AAA) - Disease Overview 13
3.2.1 Etiology and Risk Factors for the Disease 13
3.2.2 Pathophysiology 14
3.2.3 Treatment Flow Model - Peripheral Vascular Devices for the Treatment of Abdominal Aortic Aneurysm 14
3.2.4 Device-Based Treatment Modalities for Abdominal Aortic Aneurysm 15
4 Peripheral Vascular Devices - Market Characterization 17
4.1 Peripheral Vascular Devices Market, Global, Revenue ($bn), Historic, 2003–2010 17
4.2 Peripheral Vascular Devices Market, Global, Revenue ($bn), Forecast, 2010–2017 18
4.3 Peripheral Vascular Devices, Market Dynamics 20
4.3.1 Market Drivers 20
4.3.2 Market Restraints 22
4.4 Peripheral Vascular Devices Market, Global, Company Share (%), 2010 24
5 Global Peripheral Vascular Devices Market - Segment Analysis 26
5.1 Stent Grafts Market, Global, Revenue ($m), Historic, 2003–2010 26
5.2 Stent Grafts Market, Global, Revenue ($m), Forecast, 2010–2017 27
5.3 Stent Grafts, Market Dynamics 28
5.3.1 Market Drivers 28
5.3.2 Market Restraint 28
5.4 Peripheral Vascular Stents Market, Global, Revenue ($m), Historic, 2003–2010 29
5.5 Peripheral Vascular Stents Market, Global, Revenue ($m), Forecast, 2010–2017 30
5.6 Peripheral Vascular Stents, Market Dynamics 31
5.6.1 Market Drivers 31
5.6.2 Market Restraint 31
5.7 PTA Balloons Market, Global, Revenue ($m), Historic, 2003–2010 32
5.8 PTA Balloons Market, Global, Revenue ($m), Forecast, 2010–2017 33
5.9 PTA Balloons,Market Dynamics 34
5.9.1 Market Driver 34
5.9.2 Market Restraint 34
5.10 Synthetic Surgical Grafts Market, Global, Revenue ($m), Historic, 2003–2010 34
5.11 Synthetic Surgical Grafts Market, Global, Revenue ($m), Forecast, 2010–2017 36
5.12 Synthetic Surgical Grafts, Market Dynamics 37
5.12.1 Market Driver 37
5.12.2 Market Restraint 37
5.13 Inferior Vena Cava Filters Market, Global, Revenue ($m), Historic, 2003–2010 37
5.14 Inferior Vena Cava Filters Market, Global, Revenue ($m), Forecast, 2010–2017 39
5.15 Inferior Vena Cava Filters, Market Dynamics 40
5.15.1 Market Driver 40
5.15.2 Market Restraint 40
5.16 Peripheral Embolic Protection Devices Market, Global, Revenue ($m), Historic, 2003–2010 41
5.17 Peripheral Embolic Protection Devices Market, Global, Revenue ($m), Forecast, 2010–2017 42
5.18 Embolic Protection Devices, Market Dynamics 42
5.18.1 Market Driver 42
5.18.2 Market Restraint 43
5.19 Peripheral Guidewires Market, Global, Revenue ($m), Historic, 2003–2010 43
5.20 Peripheral Guidewires Market, Global, Revenue ($m), Forecast, 2010–2017 44
5.21 Peripheral Guidewires, Market Dynamics 44
5.21.1 Market Driver 44
5.21.2 Market Restraint 45
5.22 PTA Peripheral Drug Eluting Balloons Market, Global, Revenue ($m), Historic, 2003–2010 45
5.23 PTA Peripheral Drug Eluting Balloons Market, Global, Revenue ($m), Forecast, 2010–2017 46
5.24 PTA Peripheral Drug Eluting Balloons, Market Dynamics 47
5.24.1 Market Driver 47
5.24.2 Market Restraint 47
6 Peripheral Vascular Devices Market, by Country, Revenue ($m), 2003–2017 48
6.1 Peripheral Vascular Devices Market, The US, Revenue ($m), Historic, 2003–2010 48
6.2 Peripheral Vascular Devices Market, The US, Revenue ($m), Forecast, 2010–2017 50
6.3 Peripheral Vascular Devices Market, Canada, Revenue ($m), Historic, 2003–2010 52
6.4 Peripheral Vascular Devices Market, Canada, Revenue ($m), Forecast, 2010–2017 53
6.5 Peripheral Vascular Devices Market, The UK, Revenue ($m), Historic, 2003–2010 54
6.6 Peripheral Vascular Devices Market, The UK, Revenue ($m), Forecast, 2010–2017 55
6.7 Peripheral Vascular Devices Market, Germany, Revenue ($m), Historic, 2003–2010 56
6.8 Peripheral Vascular Devices Market, Germany, Revenue ($m), Forecast, 2010–2017 57
6.9 Peripheral Vascular Devices Market, France, Revenue ($m), Historic, 2003–2010 58
6.10 Peripheral Vascular Devices Market, France, Revenue ($m), Forecast, 2010–2017 59
6.11 Peripheral Vascular Devices Market, Italy, Revenue ($m), Historic, 2003–2010 60
6.12 Peripheral Vascular Devices Market, Italy, Revenue ($m), Forecast, 2010–2017 61
6.13 Peripheral Vascular Devices Market, Spain, Revenue ($m), Historic, 2003–2010 62
6.14 Peripheral Vascular Devices Market, Spain, Revenue ($m), Forecast, 2010–2017 63
6.15 Peripheral Vascular Devices Market, Japan, Revenue ($m), Historic, 2003–2010 64
6.16 Peripheral Vascular Devices Market, Japan, Revenue ($m), Forecast, 2010–2017 65
6.17 Peripheral Vascular Devices Market, China, Revenue ($m), Historic, 2003–2010 66
6.18 Peripheral Vascular Devices Market, China, Revenue ($m), Forecast, 2010–2017 67
6.19 Peripheral Vascular Devices Market, India, Revenue ($m), Historic, 2003–2010 68
6.20 Peripheral Vascular Devices Market, India, Revenue ($m), Forecast, 2010–2017 69
6.21 Peripheral Vascular Devices Market, Australia, Revenue ($m), Historic, 2003–2010 70
6.22 Peripheral Vascular Devices Market, Australia, Revenue ($m), Forecast, 2010–2017 71
6.23 Peripheral Vascular Devices Market, Brazil, Revenue ($m), Historic, 2003–2010 72
6.24 Peripheral Vascular Devices Market, Brazil, Revenue ($m), Forecast, 2010–2017 73
7 Peripheral Vascular Devices Market - Strategic Competitive Assesment 74
7.1 Peripheral Vascular Devices Market, Key Player Profiles 74
7.1.1 Cordis Corporation 74
7.1.2 Boston Scientific Corporation 77
7.1.3 Abbott Laboratories 80
7.1.4 Medtronic, Inc. 82
7.1.5 C.R. Bard, Inc. 84
8 Peripheral Vascular Devices Market - Key Marketed Products 87
8.1 Stent Grafts 87
8.1.1 Talent Abdominal Stent Graft System by Medtronic, Inc. 87
8.1.2 Zenith AAA Endovascular Graft by Cook Medical Inc. 88
8.2 Peripheral Vascular Stents 89
8.2.1 Xpert Self-Expanding Stent System by Abbott Laboratories 89
8.2.2 E- Luminexx Vascular Stent by C. R. Bard Inc. 89
8.3 PTA Balloons 91
8.3.1 Sterling ES Balloon Dilatation Catheters by Boston Scientific Corporation 91
8.3.2 OPTA Pro PTA Dilatation Catheter by Cordis Corporation 91
8.4 Synthetic Surgical Grafts 93
8.4.1 Distaflo Bypass Grafts by C.R. Bard Inc. 93
8.4.2 PV Sheath Tunneler Set by C.R. Bard Inc. 93
8.5 Inferior Vena Cava Filters 95
8.5.1 G2 X Vena Cava Filter by C. R. Bard Inc. 95
8.5.2 Optease Retrievable Vena Cava Filter by Cordis Corporation 95
8.6 Peripheral Embolic Protection Devices 97
8.6.1 RX Accunet Embolic Protection System by Abbott Laboratories 97
8.6.2 SpiderFX Embolic Protection System by ev3 Inc. 98
8.7 Peripheral Guidewires 99
8.7.1 Transend Steerable Guidewire by Boston Scientific Corporation 99
8.7.2 Cougar Guidewire by Medtronic Inc. 99
8.8 PTA Peripheral Drug Eluting Balloons (DEB) 100
8.8.1 In.Pact Pacific Amphirion Drug Eluting Balloon by Invatech, Inc. 100
8.8.2 Freeway 014 Paclitaxel Eluting Balloon by Eurocor GmbH 100
9 Peripheral Vascular Devices Market - Strategic Pipeline Assessment 102
9.1 Peripheral Vascular Devices Market - Pipeline Products Summary 102
9.2 Profiles of Promising Products under Clinical Development - Peripheral Vascular Stents 103
9.2.1 Absolute Pro Peripheral Self-Expanding Stent System 104
9.2.2 ZILVER PTX Drug Eluting Peripheral Stent 108
9.3 Profiles of Promising Products under Clinical Development - PTA Balloons 112
9.3.1 CRONUS Below-the-knee Dilatation Catheter 112
9.3.2 FREEWAY Second Generation PTA Balloon 113
9.4 Profiles of Promising Products under Clinical Development - Stent Grafts 114
9.4.1 Anaconda Endovascular Stent Graft 115
9.4.2 Zenith Fenestrated AAA Endovascular Graft 118
9.5 Profiles of Promising Products under Clinical Development - Inferior Vena Cava Filters 120
9.5.1 Crux Vena Cava Filter System 120
9.5.2 Meridian Vena Cava Filter 126
9.6 Profiles of Promising Products under Clinical Development - Peripheral Guidewires 127
9.6.1 Skipper Deep 127
9.6.2 Peripheral Guidewire-0.035 128
9.7 Profiles of Promising Products under Clinical Development - Synthetic Surgical Grafts 129
9.7.1 Fusion Bioline Vascular Graft 130
9.7.2 Next Generation Stent Graft - SFA 131
9.8 Profiles of Promising Products under Clinical Development - Embolic Protection Devices 132
9.8.1 SilverHawk with SpiderFX Embolic Protection Device 132
9.8.2 Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) 135
9.9 Profiles of Promising Products under Clinical Development - Peripheral Drug Eluting Balloons 139
9.9.1 Cotavance 139
9.9.2 In.Pact Admiral Drug Eluting Balloon 141
10 Peripheral Vascular Devices Market - Mergers and Acquisitions (M&A) Landscape 143
10.1 Peripheral Vascular Devices Market - Key Acquisitions, 2007–2010 145
10.1.1 Boston Scientific Completes Acquisition of Remaining Stake in Sadra Medical 145
10.1.2 Covidien Completes Acquisition of ev3 for $2.6 billion 145
10.1.3 C. R. Bard Completes Acquisition of FlowCardia 146
10.1.4 Medtronic Completes Acquisition of Invatec and Affiliated Companies 146
11 Appendix 147
11.1 Definitions 147
11.1.1 Peripheral Vascular Devices 147
11.1.2 Peripheral Vascular Stents 147
11.1.3 Stent Grafts 148
11.1.4 PTA Balloons 148
11.1.5 Synthetic Surgical Grafts 148
11.1.6 Inferior Vena Cava Filters 148
11.1.7 Peripheral Embolic Protection Devices 149
11.1.8 Peripheral Guidewires 149
11.1.9 PTA Peripheral Drug Eluting Balloons (DEB) 149
11.2 Acronyms 149
11.3 Research Methodology 151
11.3.1 Secondary Research 151
11.3.2 Primary Research 151
11.3.3 Models 152
11.3.4 Forecasts 152
11.3.5 Expert Panels 152
11.4 GlobalData Consulting 152
11.5 Contact Us 152
11.6 Disclaimer 153
11.7 Sources 153
1.1 List of Tables
Table 1: Peripheral Vascular Devices Market, Global, Revenue ($bn), 2003–2010 17
Table 2: Peripheral Vascular Devices Market, Global, Revenue ($bn), 2010–2017 18
Table 3: Population Aged 60 and Above as Percentage of Total Population, Global, 2010–2030 20
Table 4: Peripheral Vascular Devices Market, Global, Company Share By Revenue ($m), 2010 24
Table 5: Stent Grafts Market, Global, Revenue ($m), 2003–2010 26
Table 6: Stent Grafts Market, Global, Revenue ($m), 2010–2017 27
Table 7: Peripheral Vascular Stents Market, Global, Revenue ($m), 2003–2010 29
Table 8: Peripheral Vascular Stents Market, Global, Revenue ($m), 2010–2017 30
Table 9: PTA Balloons Market, Global, Revenue ($m), 2003–2010 32
Table 10: PTA Balloons Market, Global, Revenue ($m), 2010–2017 33
Table 11: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2003–2010 35
Table 12: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2010–2017 36
Table 13: Inferior Vena Cava (IVC) Filters Market, Global, Revenue ($m), 2003–2010 38
Table 14: Inferior Vena Cava (IVC) Filters Market, Global, Revenue ($m), 2010–2017 39
Table 15: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2003–2010 41
Table 16: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2010–2017 42
Table 17: Peripheral Guidewires Market, Global, Revenue ($m), 2003–2010 43
Table 18: Peripheral Guidewires Market, Global, Revenue ($m), 2010–2017 44
Table 19: PTA Peripheral Drug Eluting Balloons Market, Global, Revenue ($m), 2003–2010 45
Table 20: PTA Peripheral Drug Eluting Balloons Market, Global, Revenue ($m), 2010–2017 46
Table 21: Peripheral Vascular Devices Market, The US, Revenue ($m), 2003–2010 48
Table 22: Peripheral Vascular Devices Market, The US, Revenue ($m), 2010–2017 50
Table 23: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2003–2010 52
Table 24: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2010–2017 53
Table 25: Peripheral Vascular Devices Market, The UK, Revenue ($m), 2003–2010 54
Table 26: Peripheral Vascular Devices Market, The UK, Revenue ($m), 2010–2017 55
Table 27: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2003–2010 56
Table 28: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2010–2017 57
Table 29: Peripheral Vascular Devices Market, France, Revenue ($m), 2003–2010 58
Table 30: Peripheral Vascular Devices Market, France, Revenue ($m), 2010–2017 59
Table 31: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2003–2010 60
Table 32: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2010–2017 61
Table 33: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2003–2010 62
Table 34: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2010–2017 63
Table 35: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2003–2010 64
Table 36: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2010–2017 65
Table 37: Peripheral Vascular Devices Market, China, Revenue ($m), 2003–2010 66
Table 38: Peripheral Vascular Devices Market, China, Revenue ($m), 2010–2017 67
Table 39: Peripheral Vascular Devices Market, India, Revenue ($m), 2003–2010 68
Table 40: Peripheral Vascular Devices Market, India, Revenue ($m), 2010–2017 69
Table 41: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2003–2010 70
Table 42: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2010–2017 71
Table 43: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2003–2010 72
Table 44: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2010–2017 73
Table 45: Peripheral Vascular Devices, Cordis Corporation, Marketed Products, 2011 75
Table 46: Peripheral Vascular Devices, Boston Scientific, Marketed Products, 2011 78
Table 47: Peripheral Vascular Devices, Abbott Laboratories, Marketed Products, 2011 80
Table 48: Peripheral Vascular Devices, Medtronic Inc., Marketed Products, 2011 82
Table 49: Peripheral Vascular Devices, C.R. Bard Inc, Marketed Products, 2011 84
Table 50: Talent Abdominal Stent Graft System, Features and Benefits 87
Table 51: Zenith AAA Endovascular Graft, Features and Benefits 88
Table 52: Xpert Self-Expanding Stent System, Features and Benefits 89
Table 53: E- Luminexx Vascular Stent, Features and Benefits 90
Table 54: Sterling ES Balloon Dilatation Catheters, Features and Benefits 91
Table 55: OPTA Pro PTA Dilatation Catheter, Features and Benefits 92
Table 56: Distaflo Bypass Grafts, Features and Benefits 93
Table 57: PV Sheath Tunneler Set, Features and Benefits 94
Table 58: G2 X Vena Cava Filter, Features and Benefits 95
Table 59: Optease Retrievable Vena Cava Filter, Features and Benefits 96
Table 60: RX Accunet Embolic Protection System, Features and Benefits 97
Table 61: SpiderFX Embolic Protection System, Features and Benefits 98
Table 62: Transend Steerable Guidewire, Features and Benefits 99
Table 63: Cougar Guidewire, Features and Benefits 99
Table 64: In.Pact Amphirion Drug Eluting Balloon, Features and Benefits 100
Table 65: Freeway 014 Paclitaxel Eluting Balloon, Features and Benefits 101
Table 66: Peripheral Vascular Devices, Global, Pipeline Products By Device Class, 2011 102
Table 67: Peripheral Vascular Stents, List Of Pipeline Products, 2011 103
Table 68: Absolute Pro Peripheral Self-Expanding Stent System, Product Status, 2011 104
Table 69: Absolute Pro Peripheral Self-Expanding Stent System , Clinical Trial, 2011 105
Table 70: ZILVER PTX Drug Eluting Peripheral Stent, Product Status, 2011 108
Table 71: ZILVER PTX Drug Eluting Peripheral Stent, Clinical Trial 1, 2011 109
Table 72: ZILVER PTX Drug Eluting Peripheral Stent, Clinical Trial 2, 2011 110
Table 73: ZILVER PTX Drug Eluting Peripheral Stent, Clinical Trial 3, 2011 111
Table 74: PTA Balloons, List Of Pipeline Products, 2011 112
Table 75: CRONUS Below-the-knee Dilatation Catheter, Product Status, 2011 112
Table 76: FREEWAY Second Generation PTA Balloon, Product Status, 2011 113
Table 77: Stent Grafts, List Of Pipeline Products, 2011 114
Table 78: Anaconda Endovascular Stent Graft, Product Status, 2011 115
Table 79: Anaconda Endovascular Stent Graft, Clinical Trial 1, 2011 116
Table 80: Anaconda Endovascular Stent Graft, Clinical Trial 2, 2011 116
Table 81: Anaconda Endovascular Stent Graft, Clinical Trial 3, 2011 117
Table 82: Zenith Fenestrated AAA Endovascular Graft, Product Status, 2011 118
Table 83: Zenith Fenestrated AAA Endovascular Graft, Clinical Trial, 2011 119
Table 84: Inferior Vena Cava Filters, List Of Pipeline Products, 2011 120
Table 85: Crux Vena Cava Filter System, Product Status, 2011 120
Table 86: Crux Vena Cava Filter System, Clinical Trial 1, 2011 121
Table 87: Crux Vena Cava Filter System, Clinical Trial 2, 2011 123
Table 88: Crux Vena Cava Filter System, Clinical Trial 3, 2011 125
Table 89: Meridian Vena Cava Filter - Femoral version, Product Status, 2011 126
Table 90: Peripheral Guidewires, List Of Pipeline Products, 2011 127
Table 91: Skipper Deep, Product Status, 2011 127
Table 92: Peripheral Guidewire-0.035, Product Status, 2011 128
Table 93: Synthetic Surgical Grafts, List Of Pipeline Products, 2011 129
Table 94: Fusion Bioline Vascular Graft, Product Status, 2011 130
Table 95: Fusion Bioline Vascular Graft, Clinical Trial, 2011 130
Table 96: Next Generation Stent Graft - SFA, Product Status, 2011 131
Table 97: Embolic Protection Devices, List Of Pipeline Products, 2011 132
Table 98: SilverHawk With SpiderFX Embolic Protection Device, Product Status, 2011 132
Table 99: SilverHawk With SpiderFX Embolic Protection Device, Clinical Trial 1, 2011 133
Table 100: SilverHawk with SpiderFX Embolic Protection Device, Clinical Trial 2, 2011 134
Table 101: Emboshield Pro Rapid Exchange Embolic Protection System Generation 5, Product Status, 2011 135
Table 102: Emboshield Pro Rapid Exchange Embolic Protection System Generation 5, Clinical Trial 1, 2011 135
Table 103: Emboshield Pro Rapid Exchange Embolic Protection System Generation 5, Clinical Trial 2, 2011 138
Table 104: Peripheral Drug Eluting Balloons (DEB), List Of Pipeline Products, 2011 139
Table 105: Cotavance, Product Status, 2011 139
Table 106: Cotavance, Clinical Trial 1, 2011 140
Table 107: Cotavance, Clinical Trial 2, 2011 140
Table 108: Cotavance, Clinical Trial 3, 2011 141
Table 109: In.Pact Admiral Drug Eluting Balloon, Product Status, 2011 141
Table 110: In.Pact Admiral Drug Eluting Balloon, Clinical Trial, 2011 142
Table 111: Peripheral Vascular Devices Market, Global, Mergers and Acquisitions, 2007–2011* 144
1.2 List of Figures
Figure 1: Peripheral Vascular Disease, Treatment Flow Model, Global, 2010 11
Figure 2: Device Based Treatment Modalities for Peripheral Vascular Disease, 2011 12
Figure 3: Treatment Flow Model, Peripheral Vascular Devices for the Treatment of Abdominal Aortic Aneurysm , 2010 14
Figure 4: Device-Based Treatment Modalities for Abdominal Aortic Aneurysm, 2011 15
Figure 5: Peripheral Vascular Devices Market, Global, Revenue ($bn), 2003–2010 17
Figure 6: Peripheral Vascular Devices Market, Global, Revenue ($bn), 2010–2017 18
Figure 7: Peripheral Vascular Devices, Market Dynamics, 2011 19
Figure 8: Population Aged 60 and Above as Percentage of Total Population, Global, 2010–2030 20
Figure 9: Peripheral Vascular Devices Market, Global, Company Share (%), 2010 24
Figure 10: Stent Grafts Market, Global, Revenue ($m), 2003–2010 26
Figure 11: Stent Grafts Market, Global, Revenue ($m), 2010–2017 27
Figure 12: Peripheral Vascular Stents Market, Global, Revenue ($m), 2003–2010 29
Figure 13: Peripheral Vascular Stents Market, Global, Revenue ($m), 2010–2017 30
Figure 14: PTA Balloons Market, Global, Revenue ($m), 2003–2010 32
Figure 15: PTA Balloons Market, Global, Revenue ($m), 2010–2017 33
Figure 16: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2003–2010 34
Figure 17: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2010–2017 36
Figure 18: Inferior Vena Cava (IVC) Filters Market, Global, Revenue ($m), 2003–2010 37
Figure 19: Inferior Vena Cava (IVC) Filters Market, Global, Revenue ($m), 2010–2017 39
Figure 20: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2003–2010 41
Figure 21: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2010–2017 42
Figure 22: Peripheral Guidewires Market, Global, Revenue ($m), 2003–2010 43
Figure 23: Peripheral Guidewires Market, Global, Revenue ($m), 2010–2017 44
Figure 24: PTA Peripheral Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2003–2010 45
Figure 25: PTA Peripheral Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2010–2017 46
Figure 26: Peripheral Vascular Devices Market, The US, Revenue ($m), 2003–2010 48
Figure 27: Peripheral Vascular Devices Market, The US, Revenue ($m), 2010–2017 50
Figure 28: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2003–2010 52
Figure 29: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2010–2017 53
Figure 30: Peripheral Vascular Devices Market, The UK, Revenue ($m), 2003–2010 54
Figure 31: Peripheral Vascular Devices Market, The UK, Revenue ($m), 2010–2017 55
Figure 32: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2003–2010 56
Figure 33: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2010–2017 57
Figure 34: Peripheral Vascular Devices Market, France, Revenue ($m), 2003–2010 58
Figure 35: Peripheral Vascular Devices Market, France, Revenue ($m), 2010–2017 59
Figure 36: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2003–2010 60
Figure 37: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2010–2017 61
Figure 38: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2003–2010 62
Figure 39: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2010–2017 63
Figure 40: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2003–2010 64
Figure 41: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2010–2017 65
Figure 42: Peripheral Vascular Devices Market, China, Revenue ($m), 2003–2010 66
Figure 43: Peripheral Vascular Devices Market, China, Revenue ($m), 2010–2017 67
Figure 44: Peripheral Vascular Devices Market, India, Revenue ($m), 2003–2010 68
Figure 45: Peripheral Vascular Devices Market, India, Revenue ($m), 2010–2017 69
Figure 46: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2003–2010 70
Figure 47: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2010–2017 71
Figure 48: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2003–2010 72
Figure 49: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2010–2017 73
Figure 50: Peripheral Vascular Devices Market, Competitive Assessment, 2011 74
Figure 51: Cordis Corporation, SWOT Analysis, 2011 75
Figure 52: Boston Scientific, SWOT Analysis, 2011 78
Figure 53: Abbott Laboratories, SWOT Analysis, 2011 81
Figure 54: Medtronic Inc., SWOT Analysis, 2011 83
Figure 55: C.R. Bard Inc, SWOT Analysis, 2011 85
Figure 56: Peripheral Vascular Devices, Global, Pipeline Products By Device Class, 2011 102
Figure 57: Peripheral Vascular Devices Market, Global, Mergers and Acquisitions by Value ($m) and Volume, 2007–2011* 143
Companies MentionedCordis Corporation
Boston Scientific Corporation
Abbott Laboratories
Medtronic, Inc.
C.R. Bard, Inc.
To order this report:
Cardiovascular Devices Industry: Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Cardiovascular Devices Business News
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article